The estimated Net Worth of Bruce Joseph Shook is at least $231 mil dollars as of 12 November 2021. Mr. Shook owns over 7,797 units of Neuronetics Inc stock worth over $27,923 and over the last 4 years he sold STIM stock worth over $202,920. In addition, he makes $0 as Independent Director at Neuronetics Inc.
Bruce has made over 2 trades of the Neuronetics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 7,797 units of STIM stock worth $31,656 on 12 November 2021.
The largest trade he's ever made was selling 15,200 units of Neuronetics Inc stock on 27 May 2021 worth over $202,920. On average, Bruce trades about 4,599 units every 34 days since 2020. As of 12 November 2021 he still owns at least 37,734 units of Neuronetics Inc stock.
You can see the complete history of Mr. Shook stock trades at the bottom of the page.
Bruce J. Shook serves as Independent Director of the Company. Mr. Shook brings more than 30 years of medical device industry experience to the Company, including multiple early stage ventures focused on opportunities in cardiac surgery, cardiology, neurosurgery, psychiatry and vascular disease. He currently serves as Director, President and CEO for both Intact Vascular and Vesper Medical. Prior to Intact Vascular and Vesper Medical, Mr. Shook was co-founder, Director, President and CEO of Neuronetics. Previously, Mr. Shook was co-founder, Director, President and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders, and President of Abiomed (NASDAQ: ABMD), where he obtained PMA approval for the first FDA-approved ventricular assist device. Mr. Shook also developed cardiac pacing and anti-arrhythmia products at Cordis Corporation. Mr. Shook holds advanced degrees in Biomedical Engineering and Business Administration from Columbia University and the MIT Sloan School of Management. He earned a B.S. degree in Chemical Engineering from Penn State University. Mr. Shook currently serves on the Board of Directors at Venarum Medical, the Penn State Research Foundation and Life Sciences Pennsylvania. He previously served as a Director at Surgiquest, Respicardia and CoTherix.
Bruce's mailing address filed with the SEC is C/O NEURONETICS, INC, 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355.
Over the last 6 years, insiders at Neuronetics Inc have traded over $9,582,393 worth of Neuronetics Inc stock and bought 1,499,267 units worth $4,708,316 . The most active insiders traders include Capital Llc Cannell, Ronald Hunt y Glenn P Muir. On average, Neuronetics Inc executives and independent directors trade stock every 20 days with the average trade being worth of $21,199. The most recent stock trade was executed by Glenn P Muir on 5 September 2024, trading 25,000 units of STIM stock currently worth $20,000.
with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Neuronetics Inc executives and other stock owners filed with the SEC include: